Effect of Kendall Versus McKenzie Exercises in Patients With Upper Crossed Syndrome
NCT07921030, Not applicable, Recruiting, Riphah International University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effect of Kendall Versus McKenzie Exercises in Patients With Upper Crossed Syndrome | ClinicalTrials.gov |
| NCT number | NCT07921030 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 58 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Riphah International University | ClinicalTrials.gov |
| Conditions | Upper Crossed Syndrome | ClinicalTrials.gov |
| Interventions | Kendall Excercise, Mckenzie Excercise, Standard Physical Therapy | ClinicalTrials.gov |
| First posted | 2026-11-06 | ClinicalTrials.gov |
| Last updated | 2026-11-06 | ClinicalTrials.gov |
Registered outcomes 5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Numeric Pain Rating Scale | From enrollment to the end of the treatment at 6 week | patient select a whole number (0-10 integers) that best reflects the intensity of their pain. The rating scale is as follows: 0 = No pain 1-3 = Mild pain 4-6 = Moderate pain 7-10 = Severe Pain | ClinicalTrials.gov |
| Primary | Neck disability index | From enrollment to the end of the treatment at 6 week | Instructions to the client should be given to fill the questionnaire and scoring should be done by the therapist. Clients choose one of six possible replies ranging from no disability (0) to entire disability (5). The total score is calculated by adding the ten items together, ranging from 0 (no disability) to 50 (disability) (maximum disability). This score is sometimes converted to a percentage by some authors. A score of less than 4 indicates no disability, 5-14 mild disability, 15-24 moderate disability, 25-34 severe disability, and scores greater than 35 full disabilities | ClinicalTrials.gov |
| Primary | Craniovertebral angle (CVA) | From enrollment to the end of the treatment at 6 week | To measure the craniovertebral angle (CVA), participants were seated on a standard chair with their feet flat on the floor and thighs parallel to the ground. A digital phone was positioned 1.5 meters from the dominant side of each participant at shoulder height.To measure the craniovertebral angle (CVA), the angle measurement tool within the software was selected. From the file menu, the desired image was opened. Using the mouse pointer, the examiner first clicked on the tragus marker and then drew a line to the C7 marker by clicking again at that point. This line, connecting the tragus and the C7 spinous process, was then fixed. Subsequently, a horizontal line was drawn from the C7 spinous process marker, and the software calculated the angle between the two lines, which was recorded as the craniovertebral angle (CVA).Intraclass Correlation Coefficient (ICC) values was 0.89 to 0.94.The Standard Error of Measurement (SEM) ranged from 0.92° to 1.02°. | ClinicalTrials.gov |
| Secondary | Neck Flexor Muscle Endurance test | From enrollment to the end of the treatment at 6 week | Position the participant in supine crook lying, with knees bent and the head in a neutral position. Ask the participant to slightly flex the upper cervical spine (chin tuck). Instruct the participant to gently lift the head off the plinth while maintaining upper cervical flexion. Record the maximum holding time in seconds. Stop when the participant cannot maintain the position, increases neck flexion, or lowers the head. | ClinicalTrials.gov |
| Secondary | Rounded Shoulder | From enrollment to the end of the treatment at 6 week | Where a horizontal line passing through the lateral shoulder meets the line drawn from C7 to the lateral shoulder, the point of intersection forms the sagittal shoulder-C7 angle . It indicates the degree of roundness of the shoulders.It is measure by through Image J. Software | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 7
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)